Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

13,303 total articles

Keros Therapeutics Director Sells Shares Amid Stock Decline

Keros Therapeutics Director Sells Shares Amid Stock Decline

Keros Therapeutics, Inc. (NASDAQ: KROS) director Charles W. Newton executed a sale of 550 shares on June 11, 2026, totaling $5,521. The transaction, conducted under a pre-established Rule 10b5-1 trading plan adopted in March, brings his direct holdings to 12,665 shares. The sale occurs against a backdrop of significant stock depreciation, with shar…

Bridgford Foods CFO Acquires Shares Amid Trading Near 52-Week Low

Bridgford Foods CFO Acquires Shares Amid Trading Near 52-Week Low

Cindy Matthews-Morales, Chief Financial Officer and Secretary of Bridgford Foods Corp, purchased 500 shares of the company's common stock on June 15, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The transaction occurred at $6.86 per share, totaling $3,430. This purchase comes as Bridgford Foods trades near its 52-…

Abundia CEO Gillespie Acquires $12,980 Stake Amid Stock Decline

Abundia CEO Gillespie Acquires $12,980 Stake Amid Stock Decline

Edward Oliver Gillespie, Chief Executive Officer and Director of Abundia Global Impact Group, Inc. (NASDAQ: AGIG), executed an open market purchase of 11,000 shares on June 12, 2026, totaling $12,980 at $1.18 per share. This transaction brings his direct ownership to 202,248 shares. The purchase follows a significant 89% decline in AGIG stock over …

Robert D. Haas Executes $4.85M Divestiture of Levi Strauss Equity

Robert D. Haas Executes $4.85M Divestiture of Levi Strauss Equity

Robert D. Haas, a significant ten-percent shareholder in Levi Strauss & Co. (NASDAQ: LEVI), completed the sale of 202,135 shares of Class A Common Stock on June 12, 2026. The transaction, valued at $4,855,606, reflects a weighted average sale price of $24.0216 per share, with individual executions ranging between $24.00 and $24.31. The equity was h…

Royce Small-Cap Trust President Executes $50,848 Share Purchase

Royce Small-Cap Trust President Executes $50,848 Share Purchase

Christopher D. Clark, President and CEO Investment Advisor of Royce Small-Cap Trust, Inc., purchased 2,800 shares of the company's common stock on June 15, 2026. The transaction, valued at $50,848, brings his direct ownership to 50,826 shares. This insider buying activity provides a snapshot of executive alignment with the company's long-term prosp…